IZB-Start-up ions.bio

About the company
Ions.bio offers a comprehensive, all-in-one solution for biomarker discovery. We design proprietary biomarker studies, partner with clinical experts to collect samples, and convert these samples into ­extensive multi-omics datasets. These datasets are rigorously analyzed using our advanced bioinformatics and AI-driven pipeline. The outcome is a new generation of innovative biomarkers. We actively collaborate with biotech and pharma companies, providing end-to-end support and services throughout the entire biomarker discovery and validation process.

Our platform leverages cutting-edge mass spectrometry and ensures high-quality and reproducible results. Our clients benefit from our transparent project management, with regular updates and clear communication at every stage. We are committed to accelerating the transition from discovery to clinical application, helping clients unlock the full potential of their data.

What drives you?
At ions.bio, we are fueled by the desire to revolutionize healthcare through our expertise in mass spectrometry, advanced data analysis, and well-characterized bio­samples. Our goal is to make groundbreaking discoveries in clinical samples, enabling earlier disease detection and the discovery of novel therapeutic targets. By harnessing cutting-edge technology and collaborating across disciplines, our dynamic team is committed to bridging this gap. We aim to push the boundaries of bio­marker discovery, advancing precision medicine and ultimately improving patient outcomes through innovative solutions that can detect diseases sooner and guide the development of new drugs.

Contact
ions.bio
Am Klopferspitz 19
82152 Planegg-Martinsried
info@ions.bio
www.ions.bio

This article was originalle published in European Biotechnology Magazine Summer 2025.